Published studies have reported that polymorphisms in IFNGR1 are significantly associated with susceptibility of chronic hepatitis B virus infection, early gastric carcinoma, and rectal cancer [16], [38], [39]. This evidence concerns the gene IFNGR1 and rectal cancer.